Geode Capital Management, LLC Landos Biopharma, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.26 - $0.55 $181 - $384	-699 Reduced 0.76%	91,538 $27,000
Q4 2022 Feb 13, 2023	BUY	$0.22 - $0.51 $3,230 - $7,488	14,683 Added 18.93%	92,237 $46,000
Q2 2022 Aug 12, 2022	SELL	$0.6 - $1.5 $21,540 - $53,851	-35,901 Reduced 31.64%	77,554 $56,000
Q1 2022 May 13, 2022	SELL	$1.44 - $5.22 $675 - $2,448	-469 Reduced 0.41%	113,455 $167,000
Q4 2021 Feb 11, 2022	BUY	$4.7 - $15.0 $4,657 - $14,865	991 Added 0.88%	113,924 $546,000
Q3 2021 Nov 12, 2021	SELL	$9.77 - $15.77 $142,495 - $230,005	-14,585 Reduced 11.44%	112,933 $1.65 Million
Q2 2021 Aug 13, 2021	BUY	$9.26 - $12.53 $157,040 - $212,496	16,959 Added 15.34%	127,518 $1.47 Million
Q1 2021 May 12, 2021	BUY	$9.47 - $16.26 $1.05 Million - $1.8 Million	110,559 New	110,559 $1.06 Million

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.